Skip to main content
. 2021 Feb 5;23(3):513–523. doi: 10.1177/1099800421991656

Table 2.

Comparison of Alpha Diversity Indexes Between Participants Who Had Developed High Co-Occurring Symptoms and Those Who Developed Low Co-Occurring Symptoms Before CRT for Rectal Cancer (n = 41).

Diversity Index Low Co-Occurring Symptom
Group
(n = 22)
High Co-Occurring Symptom
Group
(n = 19)
p-Value*
Median (IQR) Median (IQR)
Shannon 6.66 6.49 0.87
Observed OTU 157.5 158 0.60
Pielou’s Evenness 0.91 0.89 0.28
Faith’s PD 12.47 12.28 0.89

Note. CRT = chemotherapy and radiation therapy; HAM-D = Hamilton Rating Scale for Depression; OTU = operational taxonomic units, PD = phylogenetic diversity; PROMIS-F = Patient-Reported Outcome Measures Information System-fatigue; PROMIS-SD = Patient-Reported Outcome Measures Information System-sleep disturbance.

*p-value for two-tailed Kruskal-Wallis test.